Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

Description

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

This Product Explainer is supported by CSL Seqirus

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

An Update on Heart Failure in Primary Care

Dr Gabby Mahoney

Dr Gabby Mahoney

Allergen Introduction – Practical Tips for GPs

Prof Kim Delbaere

Prof Kim Delbaere

Falls Prevention – A Practical, Evidence-Based Update on What Really Works

Dr Stephanie Daly

Dr Stephanie Daly

The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Richard Harvey

expert

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon

Date published: 24 October 2023